Eugene Storozynsky
Concepts (78)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Interleukin-3 | 2 | 1998 | 19 |
Why?
|
Dendritic Cells | 2 | 1992 | 60 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 1995 | 53 |
Why?
|
Hypertension | 2 | 2009 | 161 |
Why?
|
Fumarates | 1 | 2010 | 15 |
Why?
|
Amides | 1 | 2010 | 28 |
Why?
|
Antihypertensive Agents | 1 | 2010 | 55 |
Why?
|
Baroreflex | 1 | 2009 | 9 |
Why?
|
Electric Stimulation Therapy | 1 | 2009 | 16 |
Why?
|
Antigen Presentation | 2 | 1998 | 28 |
Why?
|
Mice, Inbred BALB C | 6 | 1992 | 176 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 1995 | 52 |
Why?
|
Neoplasms, Experimental | 2 | 1995 | 72 |
Why?
|
Tumor Cells, Cultured | 2 | 1996 | 233 |
Why?
|
Spleen | 2 | 1992 | 129 |
Why?
|
Conjunctiva | 1 | 2000 | 19 |
Why?
|
Clonal Anergy | 1 | 2000 | 20 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2000 | 17 |
Why?
|
Antigens | 1 | 2000 | 66 |
Why?
|
Lymphocyte Culture Test, Mixed | 1 | 1999 | 21 |
Why?
|
Immune Tolerance | 1 | 2000 | 72 |
Why?
|
Major Histocompatibility Complex | 1 | 1999 | 23 |
Why?
|
Immunophenotyping | 1 | 1999 | 66 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 1999 | 33 |
Why?
|
Animals | 8 | 1992 | 1032 |
Why?
|
Peptides | 1 | 2000 | 154 |
Why?
|
Lymphocyte Activation | 1 | 2000 | 137 |
Why?
|
Mice | 6 | 1992 | 623 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2000 | 113 |
Why?
|
Mice, Inbred C57BL | 2 | 1998 | 318 |
Why?
|
Prostate-Specific Antigen | 1 | 1996 | 34 |
Why?
|
Mice, Knockout | 1 | 1999 | 265 |
Why?
|
Macrophages | 1 | 1998 | 148 |
Why?
|
Cytokines | 1 | 1995 | 207 |
Why?
|
Renin-Angiotensin System | 1 | 2010 | 15 |
Why?
|
Renin | 1 | 2010 | 26 |
Why?
|
Ovalbumin | 2 | 1998 | 32 |
Why?
|
Carotid Arteries | 1 | 2009 | 51 |
Why?
|
B-Lymphocytes | 1 | 1992 | 134 |
Why?
|
Antibodies, Monoclonal | 1 | 1992 | 242 |
Why?
|
Practice Guidelines as Topic | 1 | 2010 | 174 |
Why?
|
Blood Pressure | 1 | 2009 | 205 |
Why?
|
Histocompatibility Antigens Class I | 2 | 1995 | 32 |
Why?
|
Antigen-Presenting Cells | 2 | 1992 | 40 |
Why?
|
Disease Models, Animal | 1 | 2009 | 349 |
Why?
|
Mice, Inbred DBA | 2 | 1992 | 38 |
Why?
|
Transfection | 2 | 1996 | 237 |
Why?
|
Rats | 1 | 2009 | 532 |
Why?
|
Mucous Membrane | 1 | 2000 | 37 |
Why?
|
Submandibular Gland | 1 | 2000 | 20 |
Why?
|
Injections, Subcutaneous | 1 | 2000 | 63 |
Why?
|
Administration, Topical | 1 | 2000 | 58 |
Why?
|
Immunization, Secondary | 1 | 2000 | 31 |
Why?
|
Clone Cells | 1 | 2000 | 92 |
Why?
|
Hybridization, Genetic | 1 | 1998 | 12 |
Why?
|
Humans | 3 | 1996 | 1858 |
Why?
|
Hybridomas | 1 | 1998 | 31 |
Why?
|
Lymph Nodes | 1 | 2000 | 106 |
Why?
|
Neoplasm Transplantation | 1 | 1998 | 67 |
Why?
|
Mice, Transgenic | 1 | 2000 | 209 |
Why?
|
Bone Marrow Cells | 1 | 1998 | 92 |
Why?
|
Mast-Cell Sarcoma | 1 | 1996 | 9 |
Why?
|
Eosinophils | 1 | 1995 | 30 |
Why?
|
Epitopes | 1 | 1996 | 87 |
Why?
|
Interleukins | 1 | 1995 | 32 |
Why?
|
Phenotype | 1 | 1998 | 304 |
Why?
|
Antigens, Neoplasm | 1 | 1995 | 56 |
Why?
|
T-Lymphocytes | 1 | 1998 | 182 |
Why?
|
Interferon-gamma | 1 | 1995 | 133 |
Why?
|
Organelles | 1 | 1992 | 17 |
Why?
|
Lung Neoplasms | 1 | 1996 | 160 |
Why?
|
Staining and Labeling | 1 | 1992 | 101 |
Why?
|
Microscopy, Electron | 1 | 1992 | 178 |
Why?
|
Thymus Gland | 1 | 1992 | 57 |
Why?
|
Prostatic Neoplasms | 1 | 1996 | 120 |
Why?
|
Immunohistochemistry | 1 | 1992 | 356 |
Why?
|
Male | 2 | 1992 | 1558 |
Why?
|
Female | 1 | 1992 | 1646 |
Why?
|
